Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Use of Proliferation Signal Inhibitors in Cardiac Transplantation
Howard J. Eisen
Department of Medicine
Division of Cardiology
Penn State Heart and Vascular Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of Proliferation Signal Inhibitors in Cardiac Transplantation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cardiac Transplantation
100%
Proliferation Signal Inhibitors
100%
Cardiac Allograft Vasculopathy
100%
Malignancy
66%
Clinical Trials
33%
Mammalian Target of Rapamycin (mTOR)
33%
Calcineurin Inhibitors
33%
Calcineurin
33%
Cell Proliferation
33%
Lymphocytes
33%
Long-term Survival
33%
Corticosteroids
33%
Antiproliferative Activity
33%
Successful Therapy
33%
Immunosuppressive Agents
33%
Acute Decompensated Heart Failure
33%
Smooth muscle Cell Proliferation
33%
Transplant Coronary Artery Disease
33%
Acute Cellular Rejection
33%
Mycophenolate
33%
Surgical Revascularization
33%
Percutaneous Revascularization
33%
Medicine and Dentistry
Heart Transplantation
100%
Cardiac Allograft Vasculopathy
100%
Cell Proliferation
66%
Cancer
66%
Clinical Trial
33%
Transplantation
33%
Smooth Muscle Cell
33%
Long Term Survival
33%
Coronary Artery Disease
33%
Immunosuppressive Drug
33%
Acute Graft Rejection
33%
Congestive Heart Failure
33%
Mechanistic Target of Rapamycin
33%
Calcineurin Inhibitor
33%
Revascularization
33%
Mycophenolic Acid
33%
Calcineurin
33%
Azathioprine
33%
Immunology and Microbiology
Allograft Vasculopathy
100%
Cell Proliferation
66%
Sirolimus
33%
Acute Graft Rejection
33%
Immunosuppressive Drug
33%
Coronary Artery
33%
Smooth Muscle Cell
33%
Mycophenolic Acid
33%
Azathioprine
33%
Long Term Survival
33%
Revascularization
33%
Lymphocyte
33%